GP130 modulator-1

• Description:

  GP130 modulator-1 (compound A33) is a gp130 signaling pathway modulator. GP130 modulator-1 can be used in the study of inflammatory and degenerative disorders[1].

• UNSPSC:

  12352005

• Target:

  Interleukin Related

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/gp130-modulator-1.html

• Concentration:

  10mM

• Purity:

  99.29

• Solubility:

  DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles:

  O=C(C1=CC=NO1)NC2=NC(C3=CC=C(OCCOC)C=C3)=CS2

• Molecular Formula:

  C16H15N3O4S

• Molecular Weight:

  345.37

• References & Citations:

  [1]Susan Goldsberry, et al. Small molecule modulators of gp130 signaling pathways, topical formulations and method of us thereof. WO, WO2022082071. 2022-04-21.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2375779-31-8]